The Use of Atomoxetine Adjunctively in Fibromyalgia Syndrome

Briley M Moret C. Fibromyalgia syndrome: An overview of potential drug targets. IDrugs. 2003:6: 668–73.

Patkar AA Bilal L Masand PS . Management of fibromyalgia. Curr Psychiatry Rep 2003;5:218–24.

Rowbotham MC . Other specific pain syndromes. In: Goldman L Bennett JC , editors. Cecil textbook of medicine. 21st ed. Philadelphia (PA): WB Saunders; 2000. p 2072–3.

Sayar K Aksu G Ak I Tosun M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother 2003;37:1561–5.

Clauw DJ Crofford LJ . Chronic widespread pain and fibromyalgia: What we know, and what we need to know. Best Pract Res Clin Rheumatol 2003;17:685–701.

Lautenschlager J. Present state of medication therapy in fibromyalgia syndrome. Scand J Rheumatol Suppl 2000;113:32–6.

Dryson E. Venlafaxine and fibromyalgia [letter]. N Z Med J 2000;113:87.

Dwight MM Arnold LM O'Brien H Metzger R Morris-Park E Keck PE Jr. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 1998;39:14–7.

Kratochvil CJ Vaughan BS Harrington MJ Burke WJ . Atomoxetine: A selective noradrenaline reuptake inhibitor for the treatment of attentiondeficit/hyperactivity disorder. Expert Opin Pharmacother 2003;4:1165–74.